Modification of burn shock mortality in mice by an oxidizing and a reducing agent.
D000818:Animals; D002056:Burns / Q000188:drug therapy*; D003545:Cysteine / Q000627:therapeutic use* / Q000633:toxicity; D005260:Female; D051379:Mice; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010084:Oxidation-Reduction; D012774:Shock, Traumatic / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D012965:Sodium Chloride / Q000494:pharmacology; D012996:Solutions; D014812:Vitamin K / Q000494:pharmacology / Q000627:therapeutic use*
D009943:Organophosphorus Compounds; D012996:Solutions; D014812:Vitamin K; D012965:Sodium Chloride; D003545:Cysteine